Novavax Inc. (NVAX) Insider Trading

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Mar 2023.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Mar 2023

Mar 10, 2023

Get an email when NVAX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Dec 24, 2024 – Dec 31, 2024	James F Young Director	SoldNo plan 2 parts	10,000	$8.22 average	$82k	16%	Form 4
Dec 13, 2024	Rachel K. King Director	SoldNo plan	4,150	$9.02	$37k	22%	Form 4

Dec 24, 2024 – Dec 31, 2024No plan
James F Young
Director · sold 10,000 at avg $8.22
$82k
16% of stake
Dec 13, 2024No plan
Rachel K. King
Director · sold 4,150 at $9.02
$37k
22% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch NVAX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Biological Products, (No Diagnostic Substances)

MGTXMeiraGTx Holdings plc

IMCRImmunocore Holdings plc

TWSTTwist Bioscience Corporation

KRYSKrystal Biotech Inc.

DNLIDenali Therapeutics Inc.

IOVAIovance Biotherapeutics, Inc.

ADMAAdma Biologics Inc.

ADPTAdaptive Biotechnologies Corporation

Spot a number that looks wrong? Check it in NVAX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NVAX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.